Clinical Trials Browser

Phase 3 × Enrolling by invitation × Neoplasms × Clear all

NCT05303532 2026-05-19

ROSY-D

Phase 3 Enrolling by invitation

Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Phase 3 Enrolling by invitation

Breast Neoplasms, Neoplasms